Research ArticlePharmacognosy ReviewsVol. 12 | Issue 23 | pp. 94–102Open access
A Review: Melia azedarach L. as a Potent Anticancer Drug Martha Ervina1,2,
- 1,2*,
- 3
- 1 Doctoral Program of Pharmaceutical Sciences, INDONESIA.
- 2 Department of Pharmaceutical Biology, Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya,, INDONESIA.
- 3 Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Airlangga University, Surabaya, INDONESIA.
Published in Pharmacognosy Reviews
Correspondence: Martha Ervina
Doctoral Program of Pharmaceutical Sciences, INDONESIA.; Department of Pharmaceutical Biology, Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya,, INDONESIA.
Email: marthaervina@gmail.com
- DOI:
- 10.4103/phrev.phrev_41_17
How to cite
Ervina, M., & S, S. A Review: Melia azedarach L. as a Potent Anticancer Drug Martha Ervina1,2,. Pharmacognosy Reviews, 12(23), 94–102. https://doi.org/10.4103/phrev.phrev_41_17
Abstract
Chinaberry (Melia azedarach L., Meliaceae), a Mahogany family usually used as high quality timber, is native to Asia but now is found in other parts of tropical world continent. The leaves, fruits, bark, seed and root are use in traditional medicine and it has been shown to various pharmacological activities like antifungal, anti-malarial, antibacterial, hepatoprotective, anti-oxidant, anti-fertility, anthelmintic, antipyretic and cytotoxic. A review to its phytochemical and anticancer properties of M. azedarach and its sub species or varieties as an effort to analyze the literature on its developing used as anticancer agent. As results of literatures review indicates that fruit, bark, leaves, pulp and seed of Melia azedarach L. showed various in vitro cytotoxic activities in cancer cell lines, such as human colorectal carcinoma (HT-29), breast cancer (MCF-7, SK-BR-3), cervix hepatoma (HepG-2, SMMC-7721 and Hep3B), kidney epithelial cell (MDBK), human lung adenocarcinoma epithelial cell (A549), non-small cell lung cancer (H460), human lymphoblast lung (U937), human cancer promyelocytic leukemia (HL-60), AZ521 (stomach), human colon cancer (SW480), murine colorectal adenocarcinoma cell (CT26), human oral cancer cell (KB), human prostate cancer (PC3), liver (BEL7404), CNS (SH-SY5Y, U251, SF539), B16F10 mouse melanoma cell line; and showed various in vivo to adenocarsinoma mammary in C3H mice and mouse hepatocellular carcinoma H22 cells to BALB/c mice. Previous results suggested that cytotoxic organic compounds of Melia azedarach L. were supposed of flavonoids, triterpenoids (tirucallane), limonoids (meliarachin, meliatoxin B1, trichilin H, and toosendanin), steroids, and organic acids content compounds.
Keywords
Subject
Article metadata
| Title | A Review: Melia azedarach L. as a Potent Anticancer Drug Martha Ervina1,2, |
|---|---|
| Authors | Martha Ervina; Sukardiman S |
| Affiliations | Doctoral Program of Pharmaceutical Sciences, INDONESIA.; Department of Pharmaceutical Biology, Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya,, INDONESIA.; Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Airlangga University, Surabaya, INDONESIA. |
| Corresponding author | marthaervina@gmail.com |
| Journal | Pharmacognosy Reviews |
| Volume / Issue | Vol. 12, Issue 23 |
Also in this issue
- Effects of Substances on Plants’ Active Compounds on Changes in the Hormone Levels of the Pituitary–Thyroid Axis in Hyperthyroidism and Hypothyroidismpp. 1–6
- Phytotherapeutics of Polyphenolic‑loaded Drug Delivery Systems: A Reviewpp. 7–19
- Ionic Liquid-Based Microwave-Assisted Extraction: Fast and Green Extraction Method of Secondary Metabolites on Medicinal Plantpp. 20–26
- Medicinal Plant and Their Bioactive Phytochemicals in the Treatment of Recurrent Aphthous Ulcers: A Review of Clinical Trialspp. 27–39
- Revisiting Bungur (Lagerstroemia speciosa) from Indonesia as an Antidiabetic Agent, Its Mode of Action, and Phylogenetic Positionpp. 40–45